发明名称 Use of prolactin inhibitors - for treatment of nephropathies and chronic nephritis
摘要 <p>The protection inhibitor is pref. 2-bromo-alpha-ergocryptine ergocornine, 9,10-dihydronorcornine of L-dopa and may be in the free state, or as an acid or basic addn salt. They increase the solubility of proteins (e.g. albumens and glubulins) in the urine, and relieve the symptoms of nephropathies and chronic nephritis. The prolactin inhibitors may be administered orally, parenterally or rectally, opt in combination with an antibiotic or sulphonamide, if a renal infection is also present.</p>
申请公布号 NL7303795(A) 申请公布日期 1974.09.23
申请号 NL19730003795 申请日期 1973.03.19
申请人 发明人
分类号 A61K31/135;A61K31/48;(IPC1-7):61K27/00 主分类号 A61K31/135
代理机构 代理人
主权项
地址